5Reinhold M, Deppisch W, Hermann G. Complement components as uremic toxins and their potential role as mediators of microinflammation. Kidney Int, 2001,59:271-279.
6Ikeda U, Ileda M, Seiono Y, et al. Interleukin -6 gene transcripts are expressed in atherrosclerotic lesion of the genetically hyperlipidemic rabbits. Atherosclerosis, 1992,92: 213-218.
7Antonio S, Elena M. Cardiac effects of chronic inflammation in dialysis patients. Nephrol Dial Transplant. 2002,17: 10-15.
8Kim K J, Yang WS, Kim SB, et al. Malnutrition, cardiac disease,and mortality: an integrated point of view. Am J Kindey Dis,1998, 32: 834-841.
9Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis,1998; 32: s112-s119.
10Ridker PM, Buring JE, Shin J. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparentl healthy women. Circulation, 1998,98:731-733.
1Stel VS, van de Liujtgarrden MW, Wanner C, et al. The 2008 ERA - EDTA registry annual report - a prrcis on behalf of the Eu- ropean renal registry investigators [ J] . Nephrol Dial Transplants, 2011,4 (1): 1-13.
2Sozio SM, Armstrong PA, Coresh j, et al. Cerebrovascular disease in- eidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study [J]. Am J Kidney Dis, 2013, 54 (3) : 468 -477.
